维普中文期刊产品整合服务
68篇 您的检索式:作者名="Kasamon"
    题名 作者 年代 出处 被引量
1From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors显示文摘WAHL RL JACENE H KASAMON Y 2009J Nucl Med2009,50,1:1
2FDG PET and risk-adapted therapy in Hodgkin?s and non-Hodgkin?s lymphoma显示文摘Yvette L Kasamon Richard L Wahl 2008Current Opinion in Oncology2008,,2:1
3From RECIST to PERCIST:Evolving Considerations for PET response criteria in solid tumors显示文摘Wahl RL Jacene H Kasamon Y 2009J Nucl Med2009,501,:1
4From RECIST to PER- CIST:evolving considerations for PET response criteria in solid tumors显示文摘Wahl R L Jacene H Kasamon Y 2009J Nucl Med2009,50,5:1
5From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors显示文摘Wahl RL Jacene H Kasamon Y 2009J Nucl Med2009,50,1:1
6Treatment advances in adult Burkitt lymphoma and leukemia 显示文摘Kasamon YL Swinnen LJ 2004Curr Opin Oncol2004,16,5:1
7Mean genes and the biology of aggression: a critical review of recent animal and human research 显示文摘Balaban E Alper JS Kasamon YL 1996Neurogenetics1996,11,:1
8From RECIST to PERCIST:evolving considerations for PET response crite- ria in solid tumors显示文摘Wahl RL Jacene H Kasamon Y 2009J Nucl Med2009,501,:1
9Outcomes of Nonmyeloablative HLA- Haploidentical Blood or Marrow Transplantation With High- Dose Post- Transplantation Cyclophosphamide in Older Adults显示文摘Kasamon YL Bolanos-Meade J Prince GT 2015J Clin Oncol2015,33,28:1
10From RECIST to PER- CIST:evolving considerations for PET response criteria in solid tumors显示文摘Wahl RL Jacene H Kasamon Y 2009J Nucl Meal2009,50,1:1
11Treatment advances in adult Burkitt lymphoma and leukemia 显示文摘Kasamon YI Swinnen LJ 2004Curt Opin Oncol2004,16,3:1
12From RECIST to PERCIST:evolving considerations for PET response criteria in solid tumors显示文摘Wahl RL Jacene H Kasamon Y 2009J Nucl Med2009,501,:1
13Prognostication and Risk-Adapted Therapy of Hodgkin’s Lymphoma Using Positron Emission Tomography显示文摘Yvette L. Kasamon Kensei Tobinai 2010Advances in Hematology2010,,:1
14Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome显示文摘Yvette L. Kasamon Leo Luznik Mary S. Leffell Jeanne Kowalski Hua-Ling Tsai Javier Bola?os-Meade Lawrence E. Morris Pamela A. Crilley Paul V. O’Donnell Nancy Rossiter Carol Ann Huff Robert A. Brodsky William H. Matsui Lode J. Swinnen Ivan Borrello Jonathan 2010Biology of Blood and Marrow Transplantation2010,,4:1
15From RECIST to PERCIST : evolving considerations for PET response criteria in solid tumors显示文摘Wahl RL Jacene H Kasamon Y 2009J Nucl Med2009,50,1:1
16From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors 显示文摘Wahl RL Jacene H Kasamon Y 2009J Nucl Med2009,501,:1
17Update on hormone-refractory prostate cancer显示文摘Kasamon KM Dawson NA 2004Current Opinion in Urology2004,14,3:1
18Blood or marrow transplantation for mantle cell lymphoma显示文摘Kasamon YL 2007Cure Opin Oncol2007,19,2:1
19From RECIST to PERCIST:evolving considerations for PET response criteria in solid tumors显示文摘Wahl RL Jacene H Kasamon Y 2009J Nucl Med2009,501,:1
20Nonmyeloablative HLA-haploidentical bone marrow transplantation with high- dose posttransplantation cyclophosphamide: effect of HLA dis- parity on outcome 显示文摘Kasamon YL Luznik L Leffell MS 2010Biol Blood Marrow Transplant2010,16,4:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费